News

The collaboration has expanded to complement the activities of Bayer HealthCare’s target and biomarker research program.

Both Companies collaborates to integrate Waters ACQUITY UPLC with Thermo’s mass spectrometry technology.

Nanophase will supply certain nanoparticles for a medical diagnostics application through 2014.

Now in its second year, the SCIpharm 2006 conference (May 14-17, EICC, Edinburgh, Scotland) will cover all aspects of modern R&D in a four-track format - Gene to Screen, Screen to Candidate, Candidate to Drug and Where Science Meets Business.

Through the collaboration with Windber, InforSense developed a data warehouse for integrating clinical and experimental data.

The Article validates Company's RNAi approach to discovering targets for developing molecular medicines to treat obesity and type 2 diabetes.

As a result of the transaction, Upstream Canada is now a wholly-owned subsidiary of the Company.

The extension of the DrugMatrix database will help researchers to make decisions earlier in the drug development process.

The team, led by Bert Gold, Ph.D., and Michael Dean, Ph.D., of the National Cancer Institute, identified a genetic variant that is associated with an increased risk of developing AMD.

The systems will be utilized in BASF laboratories, along with previously installed FEI Tecnai™ transmission electron microscopes.